Daily non-political popular news in brief.

Acute coronary syndrome therapy improvements linked with fewer deaths and improved clinical outcomes

Recent changes in the recommended treatments used for patients hospitalized for acute coronary syndromes, such as a heart attack, are associated with reductions in the rates of heart failure, stroke, heart attack and death, according to a study in the May 2 issue of JAMA.

Read more »

Keywords: acute, coronary, syndrome, therapy, improvements, linked, fewer, deaths, improved, clinical, outcomes, improvement, death, outcome

« Previous | Next »

Similar news on "Acute coronary syndrome therapy improvements linked with fewer deaths and improved clinical outcomes":

1. Patients at risk of adverse events within 3 months after stopping certain ACS therapy
   02-05-2008 · EurekAlert!
   Patients who receive the anti-platelet medication clopidogrel following an acute coronary syndrome (such as heart attack) appear to be at greater risk of a heart attack or death in the first 90 days after stopping clopidogrel treatment, according to a study in the Feb. 6 issue of JAMA.
   Similar news · Read more »
   
2. New therapy could preserve vessel function after heart attack
   09-10-2007 · EurekAlert!
   Scientists have identified the process that causes blood vessels to constrict during and after a heart attack. They've also demonstrated that delivering a vital molecule that is depleted during this process directly to those blood vessels can reverse damage and help restore blood flow. The medical researchers say these findings have the potential to improve outcomes for patients with acute coronary episodes related to ischemia, and to ameliorate the restriction of blood supply to the heart.
   Similar news · Read more »
   
3. Chronic disease management quality improvement efforts yield better care delivery
   03-01-2007 · EurekAlert!
   A national series of interventions designed to improve the quality of care in health centers for three prevalent chronic conditions has improved processes of care for these conditions but did not improve intermediate clinical outcomes, according to results of a study collaboratively supported by the HHS Agency for Healthcare Research and Quality and Health Resources and Services Administration and complemented by a grant from the Commonwealth Fund.
   Similar news · Read more »
   
4. Enbrel provides sustained clinical improvements for ankylosing spondylitis for up to 3 years
   11-13-2006 · EurekAlert!
   Amgen (NASDAQ: AMGN) announced patients with ankylosing spondylitis who received treatment with Enbrel (R) (etanercept) experienced sustained improvement in signs and symptoms, spinal mobility and physical function over 148 to 160 weeks of therapy, according to data from an ongoing open-label, multinational, phase 4 extension study presented at the American College of Rheumatology scientific meeting. These results are consistent with an ENBREL phase 3 clinical trial at 24 weeks.
   Similar news · Read more »
   
5. Anti-anginal drug safe but not effective in reducing major cardiac events in ACS patients
   04-24-2007 · EurekAlert!
   The anti-anginal medication ranolazine was shown to be safe in regard to certain outcomes but did not reduce the risk of major cardiovascular events such as death, heart attack or recurrent ischemia following acute coronary syndromes, according to a study in the April 25 issue of JAMA.
   Similar news · Read more »
   
6. Common drug-releasing coronary stents appear to have similar clinical outcomes
   01-29-2008 · EurekAlert!
   A comparison of use of the first two commercially available drug-releasing coronary stents (for the medications sirolimus and paclitaxel) among patients in "everyday clinical practice" indicates no significant differences for outcomes such as heart attack or cardiac death, according to a study in the Jan. 30 issue of JAMA.
   Similar news · Read more »
   
7. Vaginal progesterone gel may improve infant outcomes and...
   10-02-2007 · EurekAlert!
   A study just published in the October issue of The White Journal supports findings from last month's New England Journal of Medicine that progesterone reduces preterm birth among women with a short cervix. This is the first and only preterm birth prevention study associated with significant improvements in clinical measures of infant outcome -- with a reduction in newborns admitted to neonatal intensive care units, as well as shorter stays in the NICU for babies whose mothers were treated with vaginal progesterone gel.
   Similar news · Read more »
   
8. Studies highlight advances in diagnosis, medical therapy
   03-26-2007 · EurekAlert!
   Three studies being presented today at the American College of Cardiology’s Innovation in Intervention: i2 Summit 2007 highlight the breadth of research propelling advances in clinical cardiology. One study explores the best medical and interventional treatment for patients with acute coronary syndromes, the second demonstrates the long-lasting promise of non-surgical approaches to the repair of heart valves, and the third highlights a new drug-exercise combination that improves image quality and reduces side effects.
   Similar news · Read more »
   
9. Performance-related financial incentives for hospitals not linked with improved quality of care
   06-05-2007 · EurekAlert!
   A pay-for-performance program at hospitals was not associated with significant improvement in processes of care or outcomes for heart attack patients, according to a study in the June 6 issue of JAMA.
   Similar news · Read more »
   
10. Similar outcomes for patients with ACS treated with different anticoagulant regimens
    12-04-2007 · EurekAlert!
    Patients with acute coronary syndromes such as unstable angina who were undergoing an invasive treatment and received one of three anticoagulant regimens did not have significant differences in the rates of ischemia or death after one year, according to a study in the Dec. 5 issue of JAMA.
    Similar news · Read more »